top of page

Highlighted Publications

Kedmi, R., et. al. (2022).
Nature, 610(7933), 737-7.

 

Kedmi, R*., Veiga, N*., et.al. (2018). Nature nanotechnology, 13(3), 214-219.

Rudnitsky, A., et.al. (2024). BioRxiv.

Full list of Publications

Research papers

Rudnitsky, A., Oh, H., Talmor, J., & Kedmi, R. (2024). Coordinated network of T cells and antigen presenting cells regulate tolerance to food. 

Kedmi, R., Najar, T. A., Mesa, K. R., Grayson, A., Kroehling, L., Hao, Y., ... & Littman, D. R. (2022). A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation. Nature, 610(7933), 737-7
 

Sano, T., Kageyama, T., Fang, V., Kedmi, R., Martinez, C. S., Talbot, J., ... & Littman, D. R. (2021). Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes. Cell reports, 36(8), 109608.

Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., ... & Peer, D. (2020). CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Science advances, 6(47), eabc9450.

 

Veiga, N., Goldsmith, M., Granot, Y., Rosenblum, D., Dammes, N., Kedmi, R., ... & Peer, D. (2018). Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nature communications, 9(1), 1-9.
 

Kedmi, R*., Veiga, N*., Ramishetti, S., Goldsmith, M., Rosenblum, D., Dammes, N., ... & Peer, D. (2018). A modular platform for targeted RNAi therapeutics. Nature nanotechnology, 13(3), 214-219.

*-co-first authors

 

Ramishetti, S.*, Kedmi, R.*, Goldsmith, M., Leonard, F., Sprague, A. G., Godin, B., ... & Peer, D. (2015). Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles. ACS nano, 9(7), 6706-6716.

*-co-first authors

 

Dahan, L., Huang, L., Kedmi, R., Behlke, M. A., & Peer, D. (2013). SNP detection in mRNA in living cells using allele specific FRET probes. PloS one, 8(9), e72389.
 

Bahat, A.*, Kedmi, R.*, Gazit, K., Richardo‐Lax, I., Ainbinder, E., & Dikstein, R. (2013). TAF 4b and TAF 4 differentially regulate mouse embryonic stem cells maintenance and proliferation. Genes to Cells, 18(3), 225-237.

*-co-first authors

 

Kedmi, R.*, Ben-Arie, N.*, & Peer, D. (2010). The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials, 31(26), 6867-6875.

*-co-first authors

Review papers

Kedmi, R., & Peer, D. (2016). Zooming in on selectins in cancer. Sci. Transl. Med, 8, 345fs311.
 

Ben-Arie, N.*, Kedmi, R.*, & Peer, D. (2011). Integrin-targeted nanoparticles for siRNA delivery. In Integrin and Cell Adhesion Molecules (pp. 497-507). Humana Press, Totowa, NJ.
*-co-first authors

 

Kedmi, R., & Peer, D. (2009). RNAi nanoparticles in the service of personalized medicine. Nanomedicine, 4(8), 853-855.

bottom of page